Status:
UNKNOWN
Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment
Lead Sponsor:
National Taiwan University Hospital
Conditions:
NSCLC
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
1\. Detection EGFR mutation of cancer cells from malignant pleural effusion. 2. Established the cancer cell lines with without EGFR mutation from malignant pleural effusion.
Detailed Description
Lung cancer is the leading cause of mortality in the world. Previous study has shown that about 88% lung cancer cases belong to non-small cell lung cancer (NSCLC) in Taiwan (1). Approximately 50\~90% ...
Eligibility Criteria
Inclusion
- All malignant pleural effusion related to NSCLC between April 2008 and March 2009.
- Older than 18 years old.
- The patients who received thoracentesis
Exclusion
- The patients who are not compatible with inclusion criteria.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00752076
Start Date
April 1 2008
End Date
March 1 2011
Last Update
December 1 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100
2
National Taiwan University Hospital
Taipei, Taiwan, 100